• LAST PRICE
    0.0094
  • TODAY'S CHANGE (%)
    Trending Down-0.0004 (-3.5897%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0092 / 0.0098
  • Day Range
    Low 0.0092
    High 0.0094
  • 52 Week Range
    Low 0.0050
    High 0.0278
  • Volume
    20,002
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 0.0092
TimeVolumeRBSH
02:30 ET66660.0094
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRBSH
Rebus Holdings Inc
302.1K
-0.2x
---
United StatesRGIN
Regenicin Inc
337.7K
-0.5x
---
United StatesRFCS
Refocus Group Inc
247.9K
0.0x
---
United StatesALNAQ
Allena Pharmaceuticals Inc
244.2K
0.0x
---
United StatesIMMB
Immunotech Laboratories Inc
115.0K
0.0x
---
United StatesFWDG
FutureWorld Corp
155.6K
-0.2x
---
As of 2023-01-29

Company Information

Rebus Holdings, Inc., formerly Inspyr Therapeutics, Inc., is a pharmaceutical company focused on the research and development of novel targeted precision therapeutics for the treatment of cancer. The Company utilizes its proprietary delivery technology to enhance immuno-modulation for developed therapeutic outcomes. Its immune-oncology lead asset, RT-AR001, an adenosine A2A receptor antagonist, is differentiated by its intratumoral delivery of nano- or microparticle formulations that allows for better tumor infiltration. Its patented portfolio of adenosine receptor antagonists provides treatment based on the specific adenosine targets found in each type of cancer. The adenosine receptor modulators include A 2B antagonists, dual A 2A /A 2B antagonists, and A 2A antagonists that have broad development applicability including indications within immuno-oncology and inflammation.

Contact Information

Headquarters
2629 Townsgate Road #215WESTLAKE VILLAGE, CA, United States 91361
Phone
818-597-7552
Fax
---

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$302.1K
Revenue (TTM)
$0.00
Shares Outstanding
32.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.05
Book Value
$-0.43
P/E Ratio
-0.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.